This post was originally published on this site
IDEXX Labs announced earnings per share of $2.23 on revenue of $841.66M. Analysts polled by Investing.com anticipated EPS of $2.06 on revenue of $835.19M.
IDEXX Labs shares are down 45.38% from the beginning of the year, still down 46.39% from its 52 week high of $670.92 set on November 1, 2021.
IDEXX Labs’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
